NEW YORK(GenomeWeb News) – Bruker reported after the close of the market Wednesday that its second quarter revenues were down 13 percent year over year, but up almost 1 percent excluding negative currency effects.

For the three months ended June 30, Billerica, Mass.-based Bruker reported revenues of $396.0 million, compared to $457.4 million in Q2 2014.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.